Long-term vascular complications still represent the main cause of morbidity and mortality in diabetic patients. Although randomized long-term clinical studies comparing the effects of conventional and intensive therapy have demonstrated a clear link between hyperglycemia and the development of complications of diabetes, they have not defined the mechanism through which excess glucose results in tissue damage. Evidence has accumulated indicating that oxidative stress may play a key role in the etiology of diabetic complications. Isoprostanes are emerging as a new class of biologically active products of arachidonic acid metabolism of potential relevance to human vascular disease. Their formation in vivo seems to reflect primarily, if not exclusively, a nonenzymatic process of lipid peroxidation. Enhanced urinary excretion of 8-iso-PGF has been described in association with both type 1 and type 2 diabetes 2a mellitus, and correlates with impaired glycemic control. Besides providing a likely noninvasive index of lipid peroxidation in this setting, measurements of specific F isoprostanes in urine may provide a sensitive biochemical end point for dose-finding studies of natural and 2 synthetic inhibitors of lipid peroxidation. Although the biological effects of 8-iso-PGF in vitro suggest that it and other isoeicosanoids 2a may modulate the functional consequences of lipid peroxidation in diabetes, evidence that this is likely in vivo remains inadequate at this time.
been much debate as to whether or not hyperinsulinemia in AGEs may induce oxidative stress and growth factor subjects with type 2 diabetes may increase the coronary expression, and so on. The long list is a strong indication artery disease risk via potential adverse effects of insulin of the uncertainties in our understanding of the pathoon the myocardium or coronary arteries due to growth genesis of diabetic complications. stimulating effects or adverse effects on blood pressure,
In this article, we will present a current perspective on weight or lipids. In fact, CAD is often seen in subjects one of the above hypotheses, the oxidative stress hypothwith newly diagnosed diabetes who could not have had a esis, and will discuss the rilevance of F -isoprostanes as 2 prolonged period of hyperglycemia [11] . However, in a new markers of in vivo oxidative stress. feasibility study of intensive therapy with insulin compared with standard care in 153 men with type 2 diabetes on cardiovascular events, no differences in the rate of new 2. Oxidative stress in diabetes mellitus events were detected between groups over a 2-year followup period [12] . Furthermore, the Diabetes Insulin-Glucose Among the sequelae of hyperglycemia, excess oxidative in Acute Myocardial Infarction (DIGAMI) study [13] , with stress has captured considerable attention as a potential 620 diabetic subjects, showed that intensive insulin treatmechanism for the increased vascular disease in diabetics. ment was associated with a lower mortality rate than
The established association between atherosclerosis and standard treatment in subjects with acute myocardial lipid peroxidation in plasma [34] and within the vascular infarction (18.6% vs. 26.1%, P50.03). The United Kingwall [35] has led to a renewed interest in the oxidative dom Prospective Diabetes Study [14] also showed that stress of hyperglycemia as a potential mechanism for intensive treatment with insulin or oral sulphonylureas diabetic vascular disease. Early experimental evidence reduced the risk of myocardial infarction (15.8% vs. have supported the association between oxidative stress 18.1%, P50.052), a reduction of borderline statistical and hyperglycemia, showing that plasma from diabetic significance. Insulin treatment did not increase the risk of subjects contains increased levels of thiobarbituric acidcardiovascular disease. These studies suggest that the reactive substances [36] and lipid hydroperoxides [37] , two macrovascular complications of diabetes are more likely classic markers of lipid peroxidation. related to the degree of prevailing hyperglycemia or its Consistent with the concept of enhanced lipid peroxidaassociated cardiovascular risk factors and are not due to tion in diabetes, Gopaul et al. [38] have reported that the the administration of exogenous insulin.
average concentration of esterified 8-iso-PGF (a major   2a The relation between hyperglycemia and CAD is the F -isoprostane) in plasma from 39 patients with type 2 2 subject of considerable debate because serum glucose does diabetes was approximately threefold higher than in healnot consistently predict the existence of CAD [2, 15] , thy individuals. Catella-Lawson et al. [39] have reported a especially in type 2 diabetes [15, 16] . Presumably, this trend toward increased urinary 8-iso-PGF excretion in a 2a confusion stems from the reliance on a single blood group of 18 diabetics, with statistically significant elevaglucose measurement, as recent prospective data have tions in patients presenting with diabetic ketoacidosis. clearly established a link between a marker for chronic Finally, in our recent study [40] , urinary immunoreactive average glucose levels (HbA1 ) and cardiovascular mor-8-iso-PGF was significantly higher in a group of 62 type C 2 a bidity and mortality [17] . There is considerable con-2 and 23 type 1 patients than in age-matched control troversy with respect to the precise mechanism by which subjects by approximately twofold (Fig. 1 ). hyperglycemia may contribute to the development of CAD in diabetes. A number of equally tenable hypotheses have been suggested, including but not limited to, the Maillard, 3. Putative mechanisms of oxidative stress in diabetes or advanced glycation end product (AGE) hypothesis [18, 19] , the aldose reductase hypothesis [20] , oxidative
The molecular mechanism of biological oxidation by stress [21] [22] [23] , reductive stress (pseudohypoxia) [24, 25] , glucose was first identified in 1912 and referred as the true hypoxia [26] , carbonyl stress [27, 28] , altered lipopro-'Maillard reaction' [41] . The Maillard reaction accounts tein metabolism [27, 29, 30] , increased protein kinase C for the glucose dependent, nonenzymatic covalent modiactivity [31] , and altered growth factor [32] or cytokine fication of proteins that accompanies hyperglycemic states. [33] activities. All of these hypotheses have strong propoInitially, the Maillard reaction involves the combination of nents in academe, in medicine, and in the pharmaceutical the aldehyde group of glucose in the open-chain form with industry. The list is long, perhaps because each hypothesis amine groups on proteins to form a Schiff base followed is a different reflection of an underlying common pathoby Amadori rearrangement to form fructoselysine. This genic mechanism, or perhaps because different tissues are reversible glycosylation of amino groups, or glycation, sensitive to different mechanisms. the most direct is the autoxidation of glucose. Monosaccharides with an a-hydroxyaldehyde structure, like glucose, are subject to enediol rearrangement that results in the formation of an enediol radical ion [43] . The formation of this radical anion has two important implications. First, this species is capable of reduced molecular oxygen to form superoxide anion which, under certain circumstances, may contribute to the oxidation of lipids [44] or the activation of platelets [45] . Second, the dicarbonyl products formed by this pathway are quite reactive and may modify adjacent lysine groups to form AGEs such aś N -(carboxymethyl)lysine directly. These reactions derived from glucose enolization are, however, dependent on transition metal ions [43] , and the availability of free, redox-active transition metal ions in vivo is controversial. Recent data demonstrating glycation-induced ceruloplasmin fragmentation and free copper release offer one possible mechanism for a source of extracellular transition metals [46] . As an alternative mechanism of AGE-mediated oxidative stress, AGEs have also been shown to induce cellular lipid peroxidation through interacting with their specific surface receptor (RAGE) [47] , and this effect can be attenuated by vitamin E [48] . Regardless of the mechanism for the synthesis of AGEs, several features of AGE action can have direct influence on the progression of atherosclerosis. In fact, in addition to their role in lipid peroxidation, AGEs enhance the aggregation of human platelets ex vivo [49] . Moreover, AGE-modified albumin has also been shown to induce monocyte tissue factor expression and procoagulant activity [50] . Thus, AGE formation on proteins and lipids appears to contribute to both lipid peroxidation and platelet activation and may therefore contribute to the rapid progression of CAD in diabetic patients. One interesting point raised by several studies is the enzyme(s) responsible for free radical production in arterial vessel. NADH oxidase has been proposed to be a major 2 source of superoxide anion (O ) in normal and diseased 2 blood vessels [51] . To test this hypothesis, Lund et al. [52] 2 assessed O production in vessels from normal or diabetic carotids. These data suggest increased propensity to gener-2 ate O levels in arterial vessels from diabetic animals 2 or glycoxidation, of fructoselysine to yield a host of during treatment with NADH. Because numerous studies advanced glycation end products (AGEs) such as W-(carsuggest that the mechanism of impaired endothelium-deboxymethyl)lysine, pentosidine, and pyrroline, the formapendent relaxation in diabetes may involve inactivation of tion of which correlates directly with the vascular and nitric oxide (NO) by oxygen-derived free radicals [53, 54] , renal complications of diabetes mellitus [42] . These carboincreased activity of NAD/ NADH oxidase in diabetic hydrate-derived protein oxidation products are readily vessel could play a pivotal role in the early stage of quantified with gas chromatography / mass spectroscopy vascular complications in diabetes. and are more abundant in diabetics than in age-matched
In tissues where glucose uptake is independent of control subjects [42] .
insulin, including retina, lens, kidney, and peripheral In addition to AGE formation by oxidation of frucnerves, all tissue sites of diabetic complications, exposure toselysine, there are a number of other putative mechato elevated glucose levels causes an increase in intracellunisms that link hyperglycemia to oxidative stress. Among lar sorbitol and fructose levels due to increased activity of increases the cytosolic NADH-to-NAD ratio [56] . acid that have resulted from free-radical attack of cell The depletion of NADPH cell stores by AR may inhibit membrane phospholipids [65] or circulating LDLs [66] . In the activity of other NADPH-requiring enzymes. This contrast to classic prostaglandins, which are formed possibility is supported by the finding that human umbilithrough the action of PGH synthase isozymes from free cal vein endothelial cells exposed to 33 mmol / l glucose arachidonic acid [67], F isoprostanes are formed in situ 2 show a 42% decrease in NADPH concentration and a 34% from the fatty acid backbone esterified in membrane reduction of glutathione release into the medium [57] .
phospholipids. Isoprostanes maybe formed by either of two Moreover, the same endothelial cells cultured under conroutes of peroxidation [68, 69] , an endoperoxide mechaditions of high glucose and oxidative stress (200 mmol / l nism ( Fig. 2 , upper panel) or a dioxetane / endoperoxide H O ) reduce the supply of NADPH to various NADPHmechanism ( Fig. 2 , lower panel). In the former, the first 2 2 dependent pathways, including the reduced glutathione oxygen molecule is incorporated into the endoperoxide redox cycle [58] . Decreased levels of reduced glutathione ring to form the two hydroxyl groups on the PGF ring. In increase both the susceptibility of endothelial cells to the latter, by contrast, it is the second oxygen molecule damage by H O [57] and the cytotoxicity by a xenobiotic that is incorporated into the PGF ring. Also 5-and 15-
(1-chloro-2,4-dinitrobenzene) in K502 cells that possess hydroperoxy radicals can only form Groups VI and III by characteristics for erythroid cells [59] . On the other hand, the dioxetane / endoperoxide mechanism. The radical at there is no direct proof that tissue levels of NADPH are position 10 of arachidonic acid, by contrast, can yield depleted in vivo in diabetes.
isoprostanes by both mechanisms. Thus, hydroperoxy The hyperglycemia-induced increase in the NADH-toradicals formed at 8 and 12 have the option to proceed to 1 NAD ratio is referred to as hyperglycemic pseudohypoxia form a dioxetane ring (Fig. 2 , upper panel) or a dioxy- [56] and is thought to play a role in diabetic complications.
pentane ring (Fig. 2 , lower panel) on a competitive basis, Part of this idea is based on similarities existing between although it is not yet clear which is favored. Recent the metabolic consequences of pseudohypoxia (raised attention has focused upon Group VI isoprostanes. These 1 NADH-to-NAD ratio) and true hypoxia. Impaired blood compounds may be derived from a 9-hydroperoxy radical flow leading to ischemia has been noted in tissues exposed by the endoperoxide mechanism or from a 5-hydroperoxy to diabetic complications, such as nerve, which may radical by the dioxetane / endoperoxide mechanism. Howexplain the benefit of hyperbaric oxygen [60] . Both true ever, both are derived from an initial hydrogen atom hypoxia and pseudohypoxia may generate free radicals: the abstraction at position 7 of arachidonic acid. Abstraction at latter via an increased synthesis of prostaglandin H from carbon 13 can give rise to 11-and 15-hydroperoxy 2 prostaglandin G as the enzyme hydroperoxidase uses radicals, yielding only one series (Group III) of iso-2 NADH as cofactor [61] , the former via ischemia / reperfuprostanes. A radical at position 10 of arachidonic acid sion injury [62] . A vicious cycle might be envisaged in gives a radical at 8 and 12, which yields groups V and IV, which free radicals are both cause and consequence, at respectively. If the dioxetane mechanism is operative, the least in part, of ischemia. same 8-and 12-hydroperoxy radicals will yield Groups IV Because of mutual facilitatory interactions between the and V, respectively. After their formation, isoprostanes are main mediators of hyperglycemic damage to tissues (polyreleased from the membrane phospholipids in response to ol pathway, oxidative stress, AGEs, prostanoid metabocellular activation, presumably through a phospholipaselism), it is not surprising that correction of any of them mediated mechanism; they circulate in plasma and are may result in amelioration of endothelium-dependent excreted in the urine [70, 71] . They may circulate as the vasodilatation. In experimental diabetic neuropathy, for free form or as esters in phospholipids in plasma. The example, aminoguanidine, inhibitors of AR, and antioxifactors that regulate release of endogenous isoprostanes dants are all effective in ameliorating or preventing early from cell membranes and interconversion between the free neurovascular dysfunction [63] .
and esterified forms are presently poorly understood. It is conjecturable that hyperglycemia could influence the release of isoprostanes from cell membranes via increased
Isoprostanes as new markers of in vivo lipid
activation of protein kinase C and phospholipase A .
2 peroxidation Given the ubiquitous distribution of the precursor arachidonic acid, isoprostane biosynthesis can occur in virtually Unlike the quantitation of AGEs and AGE-modified all of the cellular players of the atherosclerotic lesion, proteins, the quantitation of lipid peroxidation in the including monocytes [72] . Indeed, coincubation of actisetting of hyperglycemia has been more problematic.
vated human monocytes with LDL resulted in a time- [74] .
these cells in proximity to atherosclerotic plaques (Fig. 3) . In addition to a cyclooxygenase-independent mechanism Concentration of 8-iso-PGF in the range of 1 nmol / l 2a of formation involving peroxidative attack on arachidonic to 1 mmol / l induces a dose-dependent increase in platelet acid, in which bicyclic endoperoxide intermediates are shape change, calcium release from intracellular stores, formed that are then reduced to give rise to isoprostanes and inositol phosphates [80, 83] . where persistent platelet activation and enhanced freeTheir formation in lipid bilayers by a free radical-catalyzed radical formation coincide. In fact, diabetes is charactermechanism may contribute importantly to alterations in the ized by platelet activation in vivo, as reflected by enhanced fluidity and integrity of cellular membranes. In addition, thromboxane metabolite excretion [88] . Immunoreactive 8-iso-PGF is a potent vasoconstrictor [78] and induces 8-iso-PGF is altered in patients with diabetes and 2a 2a
DNA synthesis in vascular smooth muscle cells, through appears to contribute to platelet activation in this setting interaction with TXA receptor [79] or perhaps with [40] . Paired urinary measurements of 8-iso-PGF and 2 2a
specific receptors [80] . Similarly, another F isoprostane 11-dehydro-TXB (a major metabolite of TXA ) in dia- betic patients revealed a highly significant linear correlaglycemia both above and below the threshold for diabetes tion between the two. Urinary immunoreactive 8-isoand cardiovascular risk, proof that hyperglygemia causes PGF was unchanged following a 2-week dosing with CAD was for long time less convincing. Establishing a 2a aspirin or indobufen, a reversible cyclooxygenase inhibitor, causal link between hyperglycemia and CAD is likely to despite complete suppression of thromboxane metabolite be difficult given that both are complex conditions. Reexcretion, indicating that the oxidative stress in diabetics is cently, it has been provided an important first step in likely to be a cause and not a consequence of platelet understanding the implications of hyperglycemia-induced activation [40] . Consistent with the hypothesis of enhanced lipid peroxidation and increased production of 8-iso-PGF 2a 8-iso-PGF formation's contribution to platelet activation in diabetic vascular disease [40] . Using a specific radioim2a in this setting, dose-dependent suppression of the former munoassay, it has been found that urinary excretion of by vitamin E supplementation was associated with compar-8-iso-PGF in diabetic patients was essentially twice that 2a able reductions in 11-dehydro-TXB excretion. Thus, of healthy age-matched control subjects (Fig. 1) . With 2 enhanced nonenzymatic peroxidation of arachidonic acid regard to urinary 8-iso-PGF excretion, similar findings 2a may provide a biochemical link between oxidant stress and were observed both for type 2 and type 1 diabetic patients platelet activation in the setting of diabetes mellitus.
[40] (Fig. 1) . These concordant observations between type The studies of 8-iso-PGF formation conducted so far 2 and type 1 diabetic patients would tend to implicate 2a appear to exclude a significant contribution from a cyclohyperglycemia as the culprit metabolic derangement, since oxygenase-dependent mechanism of biosynthesis in vivo.
this is a major common feature of both patient populations. This is particularly supported by no effects of aspirin and Consistent with this notion, we have reported that imother nonspecific cyclooxygenase inhibitors on urinary proved metabolic control of type 2 diabetic patients 8-iso-PGF in diabetic patients. The availability of selecsignificantly reduced urinary 8-iso-PGF levels by 32% 2a 2a
tive inhibitors of PGH synthase-2 will permit further [40] (Fig. 4) . Furthermore, reports that improved glycemic definition of the potential contribution of this pathway to control by pancreatic islet transplantation reduces vascular formation of 8-iso-PGF , particularly in the setting of oxidative stress and reverses antioxidant enzyme upregula2a complicated diabetes, were induction of this enzyme might tion in rats with streptozotocin-induced diabetes are conbe anticipated.
sistent with hyperglycemia as a source of oxidative stress [89] . This increase in 8-iso-PGF was significantly corre2a lated with blood glucose and increased platelet activation.
Hyperglycemia and isoprostane generation
On the basis of prior studies indicating that 8-iso-PGF 2a amplifies agonist-induced platelet aggregation [80] , these It is debated if hyperglycemia per se is causally related results strongly suggest that increased lipid peroxidation in to cardiovascular disease or is merely a marker for some diabetic patients leads to the formation of 8-iso-PGF , interventional studies and for dose selection for antioxidants employed in such clinical trials [93] . A limited number of studies have been completed during the past 5 years addressing the formation of F iso-2 prostanes in clinical settings putatively associated with oxidative damage, often as a result of long-standing metabolic abnormalities.
Persistently enhanced formation of F -isoprostanes has 2 been reported in association with several clinical conditions, including diabetes mellitus [38] [39] [40] , hypercholesterolemia [94, 95] , coronary ischemia-reperfusion syndromes [96, 97] , unstable angina [98] , chronic obstructive pulmonary disease [99] , cystic fibrosis [100] and cigarette smoking [101, 102] , conditions putatively characterized by increased lipid peroxidation in response to the complex metabolic abnormalities or various constituents of cigarette smoke. Accelerated LDL oxidation [103] as well as platelet activation [104] , are common features of these conditions.
Although diabetes mellitus is a clearly established risk factor for cardiovascular disease, the mechanism(s) respon- recognition of glycated LDL have been described in diabetic patients (reviewed in Reference [105] ). Moreover, through improved metabolic control also reduced platelet both high glucose levels and protein glycation enhance activation [40] . Taken together, these data suggest that the LDL oxidation by metal ions, and these reactions also extent of metabolic control has a profound influence on the yield advanced glycosilation end (AGE) products degree of oxidative stress and platelet activation in patients [103, 105] . In fact, LDLs isolated from type 2 diabetics with diabetes. contain higher levels of AGE products and conjugated Whether F -isoprostanes can also influence insulin dienes and are more easily oxidized by copper than native 2 resistance in diabetic patients is presently poorly under-LDL [106] . In addition, plasma from patients whose type 1 stood. Recently, Laight et al. [90] have investigated diabetes mellitus is poorly controlled has less antioxidant oxidant stress, glucose tolerance and glucose-stimulated capacity [107] . Oxidatively modified LDL has been found insulin responses in the obese Zucker rat, a widely used in foam cells and atherosclerotic plaques and has been model of insulin resistance. The plasma level of 8-isoshown to acquire a variety of properties possibly relevant PGF was elevated approximately 5-fold in old obese to the process of atherogenesis [35, 108] . 2a relative to age-matched, insulin-sensitive. Supplementation When LDL is oxidized in vitro, either by exposure to of the diet with vitamin E reduced plasma 8-iso-PGF and copper or by coincubation with endothelial cells, iso2a concomitantly reversed glucose-stimulated hyperinprostanes are formed in a time-dependent manner, along sulinemia in this experimental model. This could explain, with more conventional indices of lipid peroxidation at least in part, the beneficial effects of antioxidants on [66, 109, 110] . However, it is unknown how oxidizability of insulin action previously reported in literature [91] . How-LDL, either in vitro or ex vivo, relates to actual LDL ever, whether 8-iso-PGF plays a pivotal role also in oxidation in vivo. Isoprostanes are present in human 2a patients with hyperinsulinemia and insulin resistance but atherosclerotic plaque [74, 111] , as are isoeicosatrienoic without overt hyperglycemia is still unclear at this time.
acids, which appear to be even more abundant [112] . Formation of isoprostanes in monocytes / macrophages in atherosclerotic plaques may modify aspects of their func-7. Potential role of isoprostanes in atherosclerosis tion, such as expression of tissue factor [82] . Moreover, formation of isoprostanes in oxidized LDL results in their Given the abundant information that oxidation of LDL uptake by monocytes / macrophages, resulting in the formaconfers properties thought relevant to atherogenesis [92] , tion of foam cells. Finally, isoprostanes may also accumuthere has been interest in the potential of isoprostane late in vascular smooth muscle cell in atherosclerotic measurements both to identify patient populations for plaques (Fig. 3) . Thus, although a functional role for isoprostanes in atherogenesis remains to be established, optimal dose of vitamin E supplementation, largely bediscriminant production of isoprostanes by both reactive cause of inadequate biological end points for its efficacy. oxygen species and monocyte PGH synthase 2 within This is reflected in a wide range of vitamin E doses tested atherosclerotic plaques renders it a candidate molecule to in randomized clinical trials, from as low as 50 mg daily to transduce, at least in part, the effects of lipid peroxidation as high as |500 mg daily [115] [116] [117] , and in a broad and inflammation on vascular dysfunction. spectrum of clinical benefits, from a 60% reduction iǹ To address this hypothesis, Pratico et al. [113] have nonfatal myocardial infarction in the CHAOS study [116] recently studied isoprostane generation before and after to the absence of benefits in the recent HOPE trial [117] . A vitamin E supplementation in the hypercholesterolemic, number of mechanisms have been suggested to contribute ApoE-deficient mouse that develops atherosclerosis-type to the putative beneficial effects of vitamin E, including lesions on a chow diet. Supplementation with vitamin E inhibition of LDL oxidation and prevention of fatty streak significantly reduced isoprostane generation, but had not formation, stabilization of coronary lesions, a direct antieffect on plasma cholesterol levels in apoE knock-out platelet effect, or improvement of endothelium-dependent mice. This intervention also suppressed the elevated levels isomers. Second, these compounds may be subject to rapid to a comparable level achieved by smoking cessation reesterification after release from membrane phospholipids. [102] . Similarly, we found that supplementation with Finally, the mechanisms and regulation of their release are vitamin E up to 1200 mg did not significantly affect the poorly understood. Nonetheless, there are hints that they urinary excretion of 8-iso-PGF in chronic smokers [118] . 2a might have some relevance in vivo. A thromboxane In contrast, two-week dosing with vitamin E (100 to 600 receptor antagonist is more effective at preventing plateletmg daily) was found to reduce immunoreactive 8-isodependent coronary occlusion in dogs after thrombolysis PGF excretion in a dose-dependent fashion in type 2 2a than aspirin, despite complete inhibition of thromboxane diabetic subjects, with all measurements failing within the formation by the latter [114] . This observation suggests range of healthy subjects at 600 mg daily [40] . activation of the thromboxane receptor by a ligand distinct Failure of vitamin E supplementation to reduce thromfrom TXA and 8-iso-PGF is known to increase during boxane metabolite excretion in healthy cigarette smokers 2 2 a coronary reperfusion in this model [96] . Moreover, in [118] provides important support to the contention [40, 94] patients with unstable angina, roughly 50% of the inthat vitamin E may blunt F -isoprostane-mediated amplifi-2 dividual variation in aspirin-insensitive TXA biosynthesis cation of platelet activation in several pathological clinical 2 could be accounted for by the individual variation in setting, such as those depicted in Fig. 5 , rather than 8-iso-PGF formation [98] . Finally, vitamin E suppresses exerting a direct antiplatelet effect.
2a not only 8-iso-PGF in patients with diabetes but also the The overall picture emerging from a series of studies of 2a elevated levels of a thromboxane metabolite [40] . Perhaps, vitamin E supplementation using the in vivo formation of as suggested above, platelet active isoprostanes, such as F isoprostane as the primary biochemical end-point 2 8-iso-PGF , contribute to the enhanced platelet activation [40, 94, 102, 113, 118] suggests that the effect of vitamin E 2a in diabetic patients at risk of cardiovascular events. on lipid peroxidation can not be equated to that of a conventional drug blocking an enzyme or receptor in a reproducible fashion in the vast majority of patients 8. Effects of antioxidants exposed to treatment. Most likely, both the mechanism(s) responsible for enhanced oxidant stress and the rate of Numerous epidemiological studies have shown that lipid peroxidation are important determinants of the antidietary intake of vitamin E is inversely associated with the oxidant effects of vitamin E supplementation. This hypothrisk of cardiovascular disease, though randomized interesis may help interpreting the conflicting and largely vention trials have uncertain proved the cardiovascular disappointing results of recently completed trials of vitabenefit from vitamin treatment [115] . In general, the min E supplementation in patients with ischemic heart epidemiological studies have been interpreted to suggest disease [116, 117, 119] . Any protective effect of antioxidant that prevention of cardiovascular disease requires large intervention, that is readily apparent in the setting of amounts of vitamin E, in excess of the conventional dietary genetically determined enhanced lipid peroxidation [113] , intake. However, there is substantial uncertainty as to the is likely to be diluted by inclusion of a large proportion of relevance to diabetes and cardiovascular diseases. Their 
